Morgan Stanley »

G1 Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of G1 Therapeutics shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $915k 402k 2.28
2024-03-31 $758k 175k 4.32
2023-12-31 $519k 170k 3.05
2023-09-30 $50k 35k 1.42
2023-06-30 $358k 147k 2.43
2022-12-31 $2.0M 371k 5.43
2022-06-30 $949k 183k 5.20
2022-03-31 $2.1M 275k 7.60
2021-06-30 $13M 572k 21.95
2020-12-31 $4.2M 234k 17.98
2020-09-30 $1.6M 140k 11.58
2020-06-30 $1.0M 43k 24.26
2020-03-31 $1.7M 152k 10.98
2019-12-31 $1.8M 70k 26.42
2019-09-30 $3.7M 161k 22.82
2019-03-31 $5.9M 356k 16.61
2018-12-31 $4.0M 206k 19.16
2018-09-30 $1.9M 37k 52.29
2018-06-30 $1.9M 44k 43.46
2018-03-31 $1.1M 31k 37.04
2017-12-31 $319k 16k 19.83